Jonathan Morris

Elucidating the pathophysiology of syringomyelia

John D. Heiss, N Patronas, Hetty L. DeVroom et al. · Journal of neurosurgery · 1999 · 466 citations

Long‐Term Use of Mycophenolate Mofetil is Associated With a Reduction in the Incidence and Risk of Late Rejection

Herwig‐Ulf Meier‐Kriesche, Bettina J. Steffen, Alan M. Hochberg et al. · American Journal of Transplantation · 2003 · 128 citations

Mycophenolate Mofetil, Pharmacology, Pharmacotherapy +3

Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases

Stephanie J. Reisinger, Patrick Ryan, Donald J. O’Hara et al. · Journal of the American Medical Informatics Association · 2010 · 99 citations · Full text

Health‐economic analysis: cost‐effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease – modelling outcomes in active luminal and fistulizing disease in adults

James O. Lindsay, Yogesh Punekar, Jonathan Morris et al. · Alimentary Pharmacology & Therapeutics · 2008 · 79 citations · Full text

Gliomatosis cerebri: clinical characteristics, management, and outcomes

Selby Chen, Shota Tanaka, Caterina Giannini et al. · Journal of Neuro-Oncology · 2013 · 73 citations

Neuro-oncology, Gliomatosis Cerebri, Clinical Neurology +10